Key role for efflux in the preservative susceptibility and adaptive resistance of Burkholderia cepacia complex bacteria

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 7, 2013, Pages 2972-2980

  Rushton, Laura ^a   Sass, Andrea ^a,d   Baldwin, Adam ^b   Dowson, Christopher G ^b   Donoghue, Denise ^c   Mahenthiralingam, Eshwar ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNILEVER RESEARCH   (United Kingdom)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 BENZISOTHIAZOLIN 3 ONE; 2 METHYL 4 ISOTHIAZOLIN 3 ONE; 2 PHENOXYETHANOL; AMIKACIN; ANTIBIOTIC AGENT; BENZETHONIUM CHLORIDE; BENZOIC ACID; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DIMETHYLOL DIMETHYL HYDANTOIN; LEVOFLOXACIN; METHYL PARABEN; METHYLISOTHIAZOLINONE CHLOROMETHYLISOTHIAZOLINONE; NORFLOXACIN; SPARFLOXACIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BIOFILM; BURKHOLDERIA AMBIFARIA; BURKHOLDERIA ANTHINA; BURKHOLDERIA ARBORIS; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA CONTAMINANS; BURKHOLDERIA DIFFUSA; BURKHOLDERIA DOLOSA; BURKHOLDERIA LATA; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA STABILIS; BURKHOLDERIA UBONENSIS; BURKHOLDERIA VIETNAMIENSIS; GENE EXPRESSION; GENE MUTATION; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BASE SEQUENCE; BENZETHONIUM; BIOFILMS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; DNA TOPOISOMERASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHYLENE GLYCOLS; FLUOROQUINOLONES; HUMANS; HYDANTOINS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; OCCUPATIONAL HEALTH; PARABENS; PRESERVATIVES, PHARMACEUTICAL; SEQUENCE ANALYSIS, DNA; SODIUM BENZOATE; THIAZOLES;

EID: 84879011175     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00140-13     Document Type: Article

References (48)

1. LiPuma JJ. 2010. The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 23:299-323.
2. Mahenthiralingam E, Baldwin A, Dowson CG. 2008. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J. Appl. Microbiol. 104:1539-1551. (Pubitemid 351724983)
3. Jimenez L. 2007. Microbial diversity in pharmaceutical product recalls and environments. PDA J. Pharm. Sci. Technol. 61:383-399. (Pubitemid 350305109)
4. Torbeck L, Raccasi D, Guilfoyle DE, Friedman RL, Hussong D. 2011. Burkholderia cepacia: this decision is overdue. PDA J. Pharm. Sci. Technol. 65:535-543.
5. White J, Gilbert J, Hill G, Hill E, Huse SM, Weightman AJ, Mahenthiralingam E. 2011. Culture-independent analysis of bacterial fuel contamination provides insight into the level of concordance with the standard industry practice of aerobic cultivation. Appl. Environ. Microbiol. 77: 4527-4538.
6. Oie S, Kamiya A. 1996. Microbial contamination of antiseptics and disinfectants. Am. J. Infect. Control 24:389-395. (Pubitemid 26346840)
7. Kutty PK, Moody B, Gullion JS, Zervos M, Ajluni M, Washburn R, Sanderson R, Kainer MA, Powell TA, Clarke CF, Powell RJ, Pascoe N, Shams A, LiPuma JJ, Jensen B, Noble-Wang J, Arduino MJ, McDonald LC. 2007. Multistate outbreak of Burkholderia cenocepacia colonization and infection associated with the use of intrinsically contaminated alcohol-free mouthwash. Chest 132:1825-1831.
8. Alvarez-Lerma F, Maull E, Terradas R, Segura C, Planells I, Coll P, Knobel H, Vazquez A. 2008. Moisturizing body milk as a reservoir of Burkholderia cepacia: outbreak of nosocomial infection in a multidisciplinary intensive care unit. Critical Care 12:R10.
9. Romero-Gomez MP, Quiles-Melero MI, Pena Garcia P, Gutierrez Altes A, Garcia de Miguel MA, Jimenez C, Valdezate S, Saez Nieto JA. 2008. Outbreak of Burkholderia cepacia bacteremia caused by contaminated chlorhexidine in a hemodialysis unit. Infect. Control Hosp. Epidemiol. 29:377-378. (Pubitemid 351416993)
10. Yang CJ, Chen TC, Liao LF, Ma L, Wang CS, Lu PL, Chen YH, Hwan JJ, Siu LK, Huang MS. 2008. Nosocomial outbreak of two strains of Burkholderia cepacia caused by contaminated heparin. J. Hosp. Infect. 69:398-400.
11. Vanlaere E, Baldwin A, Gevers D, Henry D, De Brandt E, LiPuma JJ, Mahenthiralingam E, Speert DP, Dowson C, Vandamme P. 2009. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int. J. Syst. Evol. Microbiol. 59:102-111.
12. Mahenthiralingam E, Baldwin A, Drevinek P, Vanlaere E, Vandamme P, LiPuma JJ, Dowson CG. 2006. Multilocus sequence typing breathes life into a microbial metagenome. PLoS One 1:e17. doi:10.1371/journal.pone.0000017.
13. Rose H, Baldwin A, Dowson CG, Mahenthiralingam E. 2009. Biocide susceptibility of the Burkholderia cepacia complex. J. Antimicrob. Chemother. 63:502-510.
14. Coenye T, Van Acker H, Peeters E, Sass A, Buroni S, Riccardi G, Mahenthiralingam E. 2011. Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms. Antimicrob. Agents Chemother. 55:1912-1919.
15. Fernández L, Breidenstein EBM, Hancock REW. 2011. Creeping baselines and adaptive resistance to antibiotics. Drug Resist. Updat. 14:1-21.
16. Russell AD. 2004. Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon. J. Hosp. Infect. 57:97-104. (Pubitemid 38750157)
17. Abdel Malek SMA, Badran YR. 2010. Pseudomonas aeruginosa PAO1 adapted to 2-phenoxyethanol shows cross-resistance to dissimilar biocides and increased susceptibility to antibiotics. Folia Microbiol. 55:588-592.
18. McCay P, Ocampo-Sosa A, Fleming GTA. 2010. Effect of subinhibitory concentrations of benzalkonium chloride on the competitiveness of Pseudomonas aeruginosa grown in continuous culture. Microbiology 156:30-38.
19. Brozel VS, Cloete TE. 1994. Resistance of Pseudomonas aeruginosa to isothiazolone. J. Appl. Bacteriol. 76:576-582. (Pubitemid 24234561)
20. Winder CL, Al-Adham ISI, Abdel Malek SMA, Buultjens TEJ, Horrocks AJ, Collier PJ. 2000. Outer membrane protein shifts in biocide-resistant Pseudomonas aeruginosa PAO1. J. Appl. Microbiol. 89:289-295.
21. Sass A, Marchbank A, Tullis E, LiPuma JJ, Mahenthiralingam E. 2011. Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. BMC Genomics 12:373.
22. Baldwin A, Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MCJ, Govan JR, Speert DP, Lipuma JJ, Vandamme P, Dowson CG. 2005. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J. Clin. Microbiol. 43:4665-4673. (Pubitemid 41298260)
23. Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JRW, Taylor P, Vandamme P. 2000. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J. Clin. Microbiol. 38:910-913. (Pubitemid 30082711)
24. Coenye T, Vandamme P, LiPuma JJ, Govan JRW, Mahenthiralingam E. 2003. Updated version of the Burkholderia cepacia complex experimental strain panel. J. Clin. Microbiol. 41:2797-2798. (Pubitemid 36712524)
25. Orth DS, Kabara JJ, Denyer SP, Tan SK (ed). 2006. Cosmetic and drug microbiology, vol 31. Informa Healthcare, New York, NY.
26. Hareland WA, Crawford RL, Chapman PJ, Dagley S. 1975. Metabolic function and properties of 4-hydroxyphenylacetic acid 1-hydroxylase from Pseudomonas acidovorans. J. Bacteriol. 121:272-285.
27. Maillard J, Denyer SP. 2009. Emerging bacterial resistance following biocide exposure: should we be concerned? Chem. Today 27:26-28.
28. Mahenthiralingam E, Campbell ME, Henry DA, Speert DP. 1996. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J. Clin. Microbiol. 34:2914-2920. (Pubitemid 26389333)
29. Chopra AD, Ra I. 1996. Understanding antibacterial action and resistance, 2nd ed. Ellis Horwood Limited, London, United Kingdom.
30. Pope CF, Gillespie SH, Pratten JR, McHugh TD. 2008. Fluoroquinolone- resistant mutants of Burkholdena cepacia. Antimicrob. Agents Chemother. 52:1201-1203. (Pubitemid 351358419)
31. Drlica K, Malik M. 2003. Fluoroquinolones: action and resistance. Curr. Top. Med. Chem. 3:249-282.
32. Staden R, Beal KF, Bonfield JK. 2000. The Staden package, 1998. Methods Mol. Biol. 132:115-130.
33. Pagès JM, Masi M, Barbe J. 2005. Inhibitors of efflux pumps in Gramnegative bacteria. Trends Mol. Med. 11:382-389. (Pubitemid 41080580)
34. Pagès JM, Amaral L. 2009. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim. Biophys. Acta 1794:826-833.
35. Rajendran R, Quinn RF, Murray C, McCulloch E, Williams C, Ramage G. 2010. Efflux pumps may play a role in tigecycline resistance in Burkholderia species. Int. J. Antimicrob. Agents 36:151-154.
36. Peeters E, Nelis HJ, Coenye T. 2008. Evaluation of the efficacy of disinfection procedures against Burkholderia cenocepacia biofilms. J. Hosp. Infect. 70:361-368.
37. Winsor GL, Khaira B, Van Rossum T, Lo R, Whiteside MD, Brinkman FS. 2008. The Burkholderia Genome Database: facilitating flexible queries and comparative analyses. Bioinformatics 24:2803-2804. (Pubitemid 352722636)
38. Drevinek P, Holden MTG, Ge Z, Jones AM, Ketchell I, Gill RT, Mahenthiralingam E. 2008. Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infect. Dis. 8:121.
39. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. doi:10.1093/nar/29.9.e45.
40. Bazzini S, Udine C, Sass A, Pasca MR, Longo F, Emiliani G, Fondi M, Perrin E, Decorosi F, Viti C, Giovannetti L, Leoni L, Fani R, Riccardi G, Mahenthiralingam E, Buroni S. 2011. Deciphering the role of rnd efflux transporters in Burkholderia cenocepacia. PLoS One 6:e18902. doi:10.1371/journal.pone.0018902.
41. Gaille C, Kast P, Dieter H. 2002. Salicylate biosynthesis in Pseudomonas aeruginosa. Purification and characterization of PchB, a novel bifunctional enzyme displaying isochorismate pyruvate-lyase and chorismate mutase activities. J. Biol. Chem. 277:21768-21775. (Pubitemid 34952328)
42. Piddock LJ. 2006. Multidrug-resistance efflux pumps: not just for resistance. Nat. Rev. Microbiol. 4:629-636. (Pubitemid 44317025)
43. Marx CJ, Miller JA, Chistoserdova L, Lidstrom ME. 2004. Multiple formaldehyde oxidation/detoxification pathways in Burkholderia fungorum LB400. J. Bacteriol. 186:2173-2178. (Pubitemid 38381207)
44. Karatzas KAG, Webber MA, Jorgensen F, Woodward MJ, Piddock LJV, Humphrey TJ. 2007. Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J. Antimicrob. Chemother. 60:947-955. (Pubitemid 47617739)
45. Whitehead RN, Overton TW, Kemp CL, Webber MA. 2011. Exposure of Salmonella enterica serovar Typhimurium to high level biocide challenge can select multidrug resistant mutants in a single step. PLoS One 6:e22833. doi:10.1371/journal.pone.0022833.
46. Denyer SP. 1995. Mechanisms of action of antibacterial biocides. Int. Biodeterior. Biodegrad. 36:227-245.
47. Chapman JS. 2003. Biocide resistance mechanisms. Int. Biodeterior. Biodegrad. 51:133-138. (Pubitemid 36325773)
48. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, Vandamme P. 2000. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J. Clin. Microbiol. 38:3165-3173.